#trialdesign
LightNews LightNews
sbokhiria.bsky.social
Doctor visit frequency can shape your entire commercial model.

Touchpoints = time to test, diagnose, and treat.

In the US? 3 visits

South Korea? 16 visits

👉 Start your strategy there.

#HealthData #DrugLaunch #TrialDesign #KIRIAResearch #HealthCare #HealthCareData
June 25, 2025 at 5:57 PM
sarahmwalter.bsky.social
This morning one of my participant advisors called just to say “hi” and gave me a few words of encouragement and wisdom. And just a few hours later I got the go-ahead for a new research proposal! Participant support gives you power! #endalz #participantfeedback #trialdesign
December 10, 2024 at 3:11 AM
bjajournals.bsky.social
New #editorial by Thomsen & Legrand discussing the #EPITUBE trial design and biological exposure separation #trialdesign

https://www.bjanaesthesia.org/article/S0007-0912(26)00059-0/fulltext
May 31, 2026 at 4:00 AM
hhorinouchi.bsky.social
🔜 #ELCC26 @myesmo.bsky.social
🔥Adaptive escalation and de-escalation treatment for NSCLC
☑️ #Biomarker #DeEscalation #Escalation #TrialDesign
🎙️Chair: Dr. Stephanie Saw Dr. Jordi Remon
@oncoalert.bsky.social LARVOL #LCSM
March 19, 2026 at 1:21 PM
hvanspall.bsky.social
Is anyone aware of any #RCT that demonstrated the efficacy of any intervention in any CVD on the primary #endpoint of “days alive and out of the hospital”?

If so, please share.

(And what #breakfast are you having to fuel the clinical workday?)

#DAOH #TrialDesign
April 10, 2025 at 11:24 AM
drinfosec.bsky.social
From @patientled.bsky.social (on Twitter):
"We’ve released a new paper on designing & optimizing clinical trials for #LongCOVID! Strong, high-impact trials are critical & most..."
threadreaderapp.com/thread/18267...

#Covid #LongCovid #ClinicalTrial #TrialDesign #PatientLed
Thread by @patientled on Thread Reader App
@patientled: We’ve released a new paper on designing & optimizing clinical trials for #LongCOVID! Strong, high-impact trials are critical & most current ones are insufficient. The paper gives guidance...
threadreaderapp.com
August 23, 2024 at 3:02 AM
nephtimes.bsky.social
Vlado Perkovic shared his thoughts on glomerular disease clinical trial design, a topic on which he presented at #GlomConHawaii. #trialdesign #kidneydisease #glomerulardisease #nephrology #nephsky docwirenews.com/post/from-a-...
From a Standard to Platform Approach: The Next Wave of Glomerular Disease Clinical Trials | Docwire News
Vlado Perkovic discussed glomerular disease clinical trial design, including basket, umbrella, platform, and pragmatic trials, at GlomCon Hawaii 2025.
docwirenews.com
October 5, 2025 at 6:02 PM
acr-journals.bsky.social
Randomized controlled active comparator strategy trial is proposed to address whether treating to a target serum urate vs treating to avoid symptoms is more effective for optimal management of gout

ACR Open Rheumatology
doi.org/10.1002/acr2...
#Medsky #Rheumsky #trialdesign #gout
The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms. Graphical abstract created with BioRender.
March 27, 2025 at 8:06 PM
statproginc12.bsky.social
FDA targets innovative CGT trial designs in draft guidance - buff.ly/ZfV7kza #clinicaltrial #clinicaltrials #trialdesign #guidance #fda
FDA targets innovative CGT trial designs in draft guidance
The draft guidance sets out six alternative trial designs that sponsors could adopt in CGT studies, as well as guidance on endpoints and patient selection.
buff.ly
September 26, 2025 at 7:15 PM
statproginc12.bsky.social
Leveraging Technology for Efficient Trial Design - buff.ly/o6dzCvC #clinicaltrial #clinicaltrials #trialdesign #technology
Leveraging Technology for Efficient Trial Design
Teams must work together with technology solutions and optimize integration to unlock their full potential.
buff.ly
March 26, 2025 at 7:15 PM
drinfosec.bsky.social
Link to research mentioned in the thread above:

Designing and optimizing clinical trials for long COVID - ScienceDirect
www.sciencedirect.com/science/arti...

#Covid #LongCovid #ClinicalTrial #TrialDesign #PatientLed
Designing and optimizing clinical trials for long COVID
Long COVID is a debilitating, multisystemic illness following a SARS-CoV-2 infection whose duration may be indefinite. Over four years into the pandem…
www.sciencedirect.com
August 23, 2024 at 3:03 AM
ritamc.bsky.social
#MedEd #GrainOfSalt #trialdesign #outcomes
Non-inferiority trials... an inferior RCT structure?

@amtejani
@Drug_Evidence
@AKECassels https://link.springer.com/article/10.1007/s11606-017-4191-y
Non-Inferiority Trials in Medicine: Practice Changing or ...
link.springer.com
November 28, 2024 at 11:55 AM
kireports.bsky.social
Systematic Review of #TrialDesign and #Endpoints in #LupusNephritis

#VisualAbstract by @RafaelLpezMrqu2

https://www.kireports.org/article/S2468-0249(26)02711-7/fulltext
April 13, 2026 at 1:00 PM
magnusx71.bsky.social
Still the worst devaluation of randomization I have ever come across. #stats #trialdesign #experimentaldesign #mumbojumbo
Copy of an 8 year old Twitter/Facebook post saying "The most fanstastic clinical trial design ever? The worst devaluation of randomization!" and then the cited reference is: "the design is dynamic, prospective, quasi-experimental with no control group cohort study" in the journal Rev. Soc. Esp. Dolor 2017; 24:4 (201-210)
February 12, 2026 at 2:19 PM